Welcome to the LumiThera European Union Registry Study (EUROLIGHT)
EUROLIGHT is a multi-center registry study to assess the safety and effectiveness of photobiomodulation (PBM) in participants with dry age-related macular degeneration (AMD). EUROLIGHT is a prospective patient registry that will record data from dry AMD patients who are treated with PBM using the LumiThera Valeda® Light Delivery System in the EU.
Photobiomodulation is a light-based treatment that can improve cellular function in a variety of medical conditions. The EUROLIGHT registry will collect data on patients with dry AMD to better understand how PBM treatment may impact visual function and how best to treat patients with dry AMD. EUROLIGHT enables us to record the use of the Valeda treatments, assess their effectiveness in dry AMD and to monitor side effects that may occur in general practice.
We thank you for contributing to this valuable resource.